Mesoblast (ASX:MSB) Secures Medicaid Agreement for Ryoncil®
Mesoblast (ASX:MSB) enters Medicaid agreement with CMS for Ryoncil®, enabling treatment for children with SR-aGvHD.
Category: ASX-MSB
Mesoblast
Latest News
HMC Capital Limited (ASX:HMC) Declares $300M Interim FY25 Distribution and Launches Fund II
BPH Global Ltd (ASX:BP8) Reports Encouraging Phase 2 Assay Results
Vanguard Investments Australia Ltd (ASX:VIF) Announces Final ETF Distribution
Euro Manganese Inc. (ASX:EMN) Announces 5-for-1 Share Consolidation
Vanguard Investments Australia Ltd (ASX:VCF) Announces Final ETF Distributions
African Gold Limited (ASX:A1G) Announces Strong Drilling Results at Didievi Project
Mesoblast (ASX:MSB) Secures Medicaid Agreement for Ryoncil®
Andromeda Metals Limited (ASX:ADN) Enters Exclusive Negotiations for A$75M Debt Financing
WT Financial Group Limited (ASX:WTL) Forms Joint Venture with Merchant Wealth Partners
Southern Cross Electrical Engineering (ASX:SXE) Acquires Force Fire Holdings
The Hub of Australian Finance News